Tryptophan hydroxylase isoform 2 (TPH2) is an important enzyme in the synthesis of serotonin in the brain. It has been suggested that there is an association between serotonin dysfunction in the brain and suicide attempt. TPH2 genetic variants were determined in DNA samples from 305 families (336 bipolar patients). Among the bipolar patients, 86 patients had history of suicide attempt. These genetic variants were not associated with suicide attempt in bipolar disorder.
The astrocytic protein S100B might serve as a functional marker for glial dysfunction in schizophrenia. Prior studies reported increased S100B serum concentrations, especially in schizophrenic patients with persistent negative symptoms. It remained to be shown that elevated serum S100B levels in schizophrenia reflect increased CSF and brain concentrations. This study demonstrated that schizophrenics had increased S100B CSF and serum concentrations. S100B reliably reached the serum in patients with intact blood-brain-barrier and serum measurements could be used to indicate glial cell function in schizophrenia.
FEATURE REVIEW
PANDAS: current status and directions for research LA Snider, SE Swedo Children in the PANDAS subgroup are distinguished from the larger group of childhood-onset obsessivecompulsive disorder and tic disorders by their characteristic clinical course and temporal association between symptom exacerbations and Group-A beta-hemolytic streptococcal infections. Systematic research on this homogenous group of children has defined the phenomenology of the subgroup, established innovative therapies that are uniquely effective, and advanced the current understanding of the pathophysiology of post-streptococcal autoimmune neuropsychiatric disorders.
LILLY-MOLECULAR PSYCHIATRY AWARD, WINNER
Gene-environment interaction analysis of serotonin system markers with adolescent depression TC Eley, K Sugden, A Corsico, AM Gregory, P Sham, P McGuffin, R Plomin, IW Craig Genes (in the serotonin system) and environment (parent-reported social adversity) were measured in 377 adolescents each, either high or low for depression. Three of the genes were linked to depression, one just in females (serotonin transporter promoter). The latter gene, which influences the level of serotonin production, had a particularly marked effect in girls who were also experiencing high levels of social adversity, evidence for a 'gene-environment interaction'. The female adolescents replicated recently published results in adults.
LILLY-MOLECULAR PSYCHIATRY AWARD, HONORARY MENTION
Human cannabinoid receptor 1 : 5 0 exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse P-W Zhang, H Ishiguro, T Ohtsuki, J Hess, F Carillo, D Walther, ES Onaivi, T Arinami, GR Uhl
The human CB1 receptor gene encodes the brain site at which marijuana acts. The authors reported parts of the CB1 receptor gene and variants in this gene that were previously unknown. A 'TAG' group of these variants distinguished substance abusers from controls and identified brain samples with less CB1 expression. CB1 receptor gene variations are thus likely to cause individual differences in human addiction vulnerability and marijuana effects.
ORIGINAL RESEARCH ARTICLES
Acute amygdalar activation induces an upregulation of multiple monoamine G protein coupled pathways in rat hippocampus FM Benes, RE Burke, D Matzilevich, J Walsh, S Berretta, C Konradi, M Minns Amygdalar activation of the hippocampus induced increased expression of multiple genes implicated in the pathophysiology of psychosis. Several of these genes encoded monoamine G-protein-coupled receptors that influenced important signaling mechanisms inside neurons. Eight out of nine of the monoamine GPCRs had moderate to high affinity for the atypical antipsychotic drug, clozapine, suggesting that its unique efficacy in treating psychosis may be related to its ability to block hippocampal monoamine GPCRs activated by the amygdala.
GM1 ganglioside regulates the proteolysis of amyloid precursor protein Q Zha, Y Ruan, T Hartmann, K Beyreuther, D Zhang
Plaques containing amyloid b-peptides (Ab) are a major feature in Alzheimer's disease and GM1 ganglioside is an important component of cellular plasma membranes and especially enriched in lipid raft. The authors reported a novel finding that exogenous GM1 ganglioside promoted Ab biogenesis and decreased sAPPa secretion in APP695 cDNA stably transfected cells without affecting full-length APP and the sAPPb levels. These findings suggest a regulatory role for GM1 in APP processing pathways.
b-sheet breaker peptide prevents Ab-induced spatial memory impairments with partial reduction of amyloid deposits MA Chaco´n, MI Barrı´a, C Soto, NC Inestrosa
The authors assessed the neuroprotective effect of the chronic intraperitoneal administration of a b-sheet breaker peptide (iAb5p) on the rat behavioral deficit induced by the intrahippocampal Ab-fibrils injection. Treated animals showed a partial reduction of the amyloid deposits and a decreased astrocytic response. More importantly, following the iAb5p treatment, hippocampal-dependent spatial learning paradigms showed a significant prevention from impairments induced by Ab deposits. Thus, the b-sheet breaker peptides treatment is suggested as a potential therapy for Alzheimer's disease patients.
Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish highdensity families X Chen, X Wang, AF O'Neill, D Walsh, KS Kendler
The COMT gene was studied for its association with schizophrenia in the Irish high-density schizophrenia families. The results provided supporting evidence that the Val/Met polymorphism is associated with schizophrenia; specifically, the Val allele might carry an increased liability to the disease. This is consistent with other family-based studies that used Caucasian samples. However, the authors failed to replicate the haplotype finding by Shifman et al.
Examination of AVPR1a as an autism susceptibility gene TH Wassink, J Piven, VJ Vieland, J Pietila, RJ Goedken, SE Folstein, VC Sheffield One biomolecular pathway that clearly influences social behavior, a key feature that is impaired in autism, is the arginine-vasopressin (AVP) system. AVP behavioral effects are mediated through the AVP receptor 1a (AVPR1a), making it a reasonable candidate for autism susceptibility. The authors tested the gene's exons in 135 independent autistic probands and genotyped two promoter polymorphisms in 65 autism-affected sibling pair (ASP) families. Although the authors did not find nonconservative coding sequence changes, they did identify evidence of linkage and of linkage disequilibrium. These results were most pronounced in a subset of the ASP families with relatively less severe impairment of language.
